JP2006525299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525299A5 JP2006525299A5 JP2006506208A JP2006506208A JP2006525299A5 JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5 JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5
- Authority
- JP
- Japan
- Prior art keywords
- azetidine
- alkyl
- pharmaceutical composition
- aryl
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0310052 | 2003-05-01 | ||
| PCT/GB2004/001884 WO2004096794A1 (en) | 2003-05-01 | 2004-04-29 | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525299A JP2006525299A (ja) | 2006-11-09 |
| JP2006525299A5 true JP2006525299A5 (enExample) | 2007-06-21 |
Family
ID=33397040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506208A Pending JP2006525299A (ja) | 2003-05-01 | 2004-04-29 | アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20070173486A1 (enExample) |
| EP (1) | EP1618105A1 (enExample) |
| JP (1) | JP2006525299A (enExample) |
| WO (1) | WO2004096794A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060019587A (ko) | 2003-06-11 | 2006-03-03 | 머크 앤드 캄파니 인코포레이티드 | 치환된 3-알킬 및 3-알케닐 아제티딘 유도체 |
| US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
| US7906652B2 (en) | 2005-11-28 | 2011-03-15 | Merck Sharp & Dohme Corp. | Heterocycle-substituted 3-alkyl azetidine derivatives |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| JP5079630B2 (ja) | 2008-08-08 | 2012-11-21 | 株式会社小松製作所 | 排気ガス浄化装置 |
| JP5033736B2 (ja) | 2008-08-08 | 2012-09-26 | 株式会社小松製作所 | 排気ガス浄化装置 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| SG178880A1 (en) | 2009-08-26 | 2012-04-27 | Sanofi Sa | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| US8846666B2 (en) | 2011-03-08 | 2014-09-30 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2671870A1 (en) * | 2012-06-05 | 2013-12-11 | Bioprojet | Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications |
| US11141404B1 (en) * | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
| US11795146B2 (en) | 2021-10-11 | 2023-10-24 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU39992B (en) * | 1976-04-02 | 1985-06-30 | Janssen Pharmaceutica Nv | Process for obtaining new piperazine and piperidine derivatives |
| US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
| JPH03264562A (ja) * | 1989-05-22 | 1991-11-25 | Hokuriku Seiyaku Co Ltd | ピペリジン誘導体 |
| CA2015949A1 (en) * | 1989-05-22 | 1990-11-22 | Yasuo Ito | Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same |
| JPH09278737A (ja) * | 1996-02-16 | 1997-10-28 | Tanabe Seiyaku Co Ltd | フェノール誘導体及びその製法 |
| JP3194355B2 (ja) * | 1996-10-24 | 2001-07-30 | 宇部興産株式会社 | ピペリジン化合物及びその製法 |
| AU7079998A (en) * | 1997-04-25 | 1998-11-24 | Takeda Chemical Industries Ltd. | Condensed pyridazine derivatives, their production and use |
| US6403574B1 (en) * | 1998-01-23 | 2002-06-11 | Vernalis Research Limited | Azetidinecarboxamide derivatives for treating CNS disorders |
| EP1067130A4 (en) * | 1998-12-04 | 2004-02-11 | Toray Industries | TRIAZOLO DERIVATIVES, AND CHIMIOKIN INHIBITORS CONTAINING THESE DERIVATIVES AS ACTIVE INGREDIENT |
| GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
| US20050009730A1 (en) * | 2001-10-16 | 2005-01-13 | Dale Edgar | Treatment of cns disorders using cns target modulators |
-
2004
- 2004-04-29 EP EP04730303A patent/EP1618105A1/en not_active Withdrawn
- 2004-04-29 WO PCT/GB2004/001884 patent/WO2004096794A1/en not_active Ceased
- 2004-04-29 JP JP2006506208A patent/JP2006525299A/ja active Pending
- 2004-04-29 US US10/554,447 patent/US20070173486A1/en not_active Abandoned
-
2009
- 2009-03-19 US US12/407,021 patent/US20090181939A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2595902C2 (ru) | Замещенные бензамидные производные | |
| RU2569887C2 (ru) | Производные оксазолинов для лечения расстройств цнс | |
| CN1440402A (zh) | 作为趋化因子受体活性调节剂的n－脲基杂环烷基－哌啶 | |
| CN107001259B (zh) | 作为taar配体的取代的氮杂环丁烷衍生物 | |
| JP2006525298A5 (enExample) | ||
| JP2013516415A5 (enExample) | ||
| RU2011115111A (ru) | Замещенные пирролидин-2-карбоксамиды | |
| JP2005526723A5 (enExample) | ||
| WO2007052843A1 (ja) | 複素環アミド化合物およびその用途 | |
| JP2006514942A5 (enExample) | ||
| ZA200603941B (en) | Derivatives of N-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| JP2017524026A5 (enExample) | ||
| RU2009138219A (ru) | Новые бензамидные производные и способ их получения | |
| JP2012500783A5 (enExample) | ||
| CN104024250A (zh) | 作为痕量胺相关受体(taar)的杂环衍生物 | |
| JP2006525299A (ja) | アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用 | |
| JP2010504323A5 (enExample) | ||
| JP6186495B2 (ja) | Ｃｅｔｐ抑制活性を有する新規なオキサゾリジノン誘導体、その製造方法およびこれを含む薬学組成物 | |
| RU2625798C2 (ru) | Производные (3-метилпирролидин-3-ил)-метил пиридинилового эфира и их применение в качестве антагонистов рецептора nk-3 | |
| JP5677457B2 (ja) | ピロリジン誘導体 | |
| RU2690154C2 (ru) | Производные морфолин-пиридина | |
| JP5410536B2 (ja) | ３−（ベンジルアミノ）−ピロリジン誘導体及びｎｋ−３受容体アンタゴニストとしてのその使用 | |
| JP2011524397A (ja) | Ｎｋ受容体アンタゴニストとしてのピロリジン誘導体 | |
| CA2713412C (en) | Amide derivative and pharmaceutical composition containing the same | |
| RU2006135486A (ru) | Производные n-пиперидина в качестве модуляторов ссr3 |